22 completed, 1 terminated. 23 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 23 | Completed 22, Terminated 1 |
Follow glimepiride: new trials by email Literature Review of glimepiride trials Research Report on glimepiride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg Evogliptin→Evogliptin+Glimepiride→Glimepiride, Glimepiride→Evogliptin→Evogliptin+Glimepiride - Type2 Diabetes | Phase 1 | Completed | Dong-A ST Co., Ltd. | 36 | 2016-11-14 | 2017-09-18 |
| Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin Bexagliflozin, Metformin, Glimepiride - Type2 Diabetes Mellitus | Phase 1 | Completed | Theracos | 54 | 2016-11-01 | 2021-07-22 |
| Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects Gemigliptin and Glimepiride, Glimepiride - Healthy | Phase 1 | Completed | LG Life Sciences | 27 | 2013-02-01 | 2013-04-23 |
| Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) Placebo, Linagliptin, Glimepiride - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Boehringer Ingelheim | 42 | 2012-10-01 | 2015-01-19 |
| Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers Metformin, 500 mg extended release tablet, Metformin, 1000 mg extended release tablet, Glimepiride, 1 mg immediate release tablet - Diabetes Mellitus, Type 2 | Phase 1 | Terminated | GlaxoSmithKline | 20 | 2012-09-27 | 2017-06-12 |
| Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253) Placebo, Glimepiride 2 mg, Glimepiride 4 mg - Type 2 Diabetes Mellitus | Phase 1 | Completed | Merck Sharp & Dohme LLC | 10 | 2012-07-18 | 2018-08-16 |
| TAK-875 Glimepiride Drug-Interaction Study TAK-875 and Glimepiride - Pharmacokinetics | Phase 1 | Completed | Takeda | 28 | 2012-01-01 | 2012-09-13 |
| BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study Glimepiride/ Extended release Metformin - Healthy | Phase 1 | Completed | Laboratorios Silanes S.A. de C.V. | 24 | 2011-01-01 | 2021-05-06 |
| BIOAVAILABILITY OF GLI/METXR (4/850 mg) Glimepiride / Extended release Metformin (4/850 mg). - Healthy | Phase 1 | Completed | Laboratorios Silanes S.A. de C.V. | 24 | 2011-01-01 | 2021-05-06 |
| The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea CKD-501 0.5 mg tablet, Glimepiride 4 mg tablet, CKD-501 placebo tablet, Glimepiride 4 mg tablet - Healthy Male Volunteer | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 24 | 2010-05-01 | 2010-12-10 |
| Drug-drug Interaction Study With ASP1941 and Glimepiride ASP1941, Glimepiride - Healthy Subjects | Phase 1 | Completed | Astellas Pharma Inc | 52 | 2009-12-01 | 2011-02-23 |
| Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male Volunteers BI 10773, Glimepiride - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 16 | 2009-04-01 | 2014-06-24 |
| Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects Dapagliflozin, Glimepiride, Sitagliptin - Type 2 Diabetes Mellitus | Phase 1 | Completed | AstraZeneca | 18 | 2009-03-01 | 2016-10-17 |
| Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg Amaryl M SR 1/500 mg, Amaryl M SR 2/500 mg - Healthy | Phase 1 | Completed | Handok Inc. | 33 | 2008-10-01 | 2009-07-08 |
| Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects Dapagliflozin, Glimepiride, Dapagliflozin + Glimepiride - Diabetes Mellitus, Type 2 | Phase 1 | Completed | AstraZeneca | 11 | 2008-05-01 | 2016-10-17 |
| Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg Amaryl-M 2/500 mg, Amaryl-M 1/500 mg - Healthy | Phase 1 | Completed | Handok Inc. | 36 | 2007-03-01 | 2009-07-08 |
| Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes liraglutide, placebo, glimepiride - Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Completed | Novo Nordisk A/S | 43 | 2005-11-01 | 2017-01-25 |
| Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg Glimepiride Tablets 1 mg, Amaryl® Tablets 1 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 40 | 2004-11-01 | 2024-04-24 |
| Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg Glimepiride Tablets 1 mg, Amaryl® Tablets 1 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 40 | 2004-11-01 | 2024-04-24 |
| Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition Glimepiride - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 44 | 2003-12-01 | 2010-01-21 |
Showing 20 of 23. Sign in to see all of them.
Diabetes Mellitus, Type 2 (6) · Diabetes Mellitus (2)
AstraZeneca (2) · Boehringer Ingelheim (2) · Dr. Reddy's Laboratories Limited (2) · Handok Inc. (2) · Laboratorios Silanes S.A. de C.V. (2) · Mylan Pharmaceuticals Inc (2) · Teva Pharmaceuticals USA (2) · Astellas Pharma Inc (1) · Chong Kun Dang Pharmaceutical (1) · Dong-A ST Co., Ltd. (1) · GlaxoSmithKline (1) · LG Life Sciences (1) · Merck Sharp & Dohme LLC (1) · Novo Nordisk A/S (1) · Takeda (1)
United States (7) · South Korea (4) · Australia (2) · Canada (2) · Germany (2) · Mexico (2) · Argentina (1) · Netherlands (1)
Benoit Girard, MD (2) · In-Jin Jang, Professor (2) · James D Carlson, Pharm. D. (2) · Solomon G. Ghide, M.D. (2) · Ji Young Park, Ph.D. (1) · Kyun-Seop Bae, M.D., Ph.D. (1) · Kyung-Sang Yu, M.D., Ph.D. (1) · Mason Freeman, M.D. (1)
PMID 10454950, PMID 1490793, PMID 8569826, PMID 9209206, PMID 9793597, PMID 22036245, PMID 22446097, PMID 28109295
2009 (1)